FDA Approves OTC Nasal Spray
The FDA's approval of a third over-the-counter opioid overdose nasal spray marks another important step in expanding access to life-saving medications.
By stocking OTC naloxone products and educating patients, caregivers, schools, businesses, and community organizations on their use, independent pharmacies can further their role as a community healthcare provider by:
✔ Increasing community access to overdose reversal medications
✔ Strengthening public health outreach efforts
✔ Positioning themselves as trusted healthcare resources beyond prescription dispensing
✔ Playing a critical role in addressing the ongoing opioid crisis
As naloxone becomes increasingly accessible, independent pharmacies remain uniquely positioned to bridge the gap between availability and awareness—ensuring these life-saving products reach the people who need them most.
Comments